Arvind Thakkar
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Genomics, phytochemicals, and oxidative stress 5
- S100 Proteins and Annexins 2
- RNA Interference and Gene Delivery 2
- Sphingolipid Metabolism and Signaling 2
- Oncology 7
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Sunil Prabhu (13 shared papers)Jeffrey Wang (12 shared papers)Dhruvitkumar S. Sutaria (2 shared papers)Zhijun Wang (2 shared papers)Muralidhara Padigaru (4 shared papers)Girish V. Shah (4 shared papers)Baoyue Ding (1 shared paper)Ravishankar Ravishankar (2 shared papers)
- Journals
- Cancer Research (3 papers)Cell & Bioscience (2 papers)International Journal of Oncology (2 papers)Oncology Reports (2 papers)Cancer Prevention Research (2 papers)
- Partner nations
- United StatesIndiaNetherlands
In The Last Decade
Arvind Thakkar
22 papers receiving 546 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 68
- Biomaterials 125
- Pharmaceutical Science 45
- Toxicology 17
- Cancer Research 70
Countries citing papers authored by Arvind Thakkar
This map shows the geographic impact of Arvind Thakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Thakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Thakkar more than expected).
Fields of papers citing papers by Arvind Thakkar
This network shows the impact of papers produced by Arvind Thakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Thakkar. The network helps show where Arvind Thakkar may publish in the future.
Co-authors
The 24 scholars most cited alongside Arvind Thakkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 71 | |
| 2 | 2015 | 58 | |
| 3 | 2012 | 56 | |
| 4 | 2014 | 41 | |
| 5 | 2010 | 35 | |
| 6 | 2016 | 35 | |
| 7 | 2013 | 33 | |
| 8 | 2013 | 29 | |
| 9 | 2019 | 28 | |
| 10 | 2015 | 25 | |
| 11 | 2015 | 25 | |
| 12 | 2014 | 23 | |
| 13 | Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma. | 2018 | 19 |
| 14 | 2016 | 17 | |
| 15 | 2015 | 16 | |
| 16 | 2011 | 13 | |
| 17 | 2017 | 9 | |
| 18 | 2013 | 6 | |
| 19 | 2010 | 5 | |
| 20 | 2015 | 2 |
About Arvind Thakkar
Arvind Thakkar is a scholar working on Molecular Biology, Oncology, Molecular Medicine, Cancer Research and Cellular and Molecular Neuroscience, having authored 22 papers that have together received 549 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Neuropeptides and Animal Physiology (3 papers), S100 Proteins and Annexins (2 papers), RNA Interference and Gene Delivery (2 papers), Barrier Structure and Function Studies (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). The work is most often cited by research in Molecular Medicine (68 citations), Biomaterials (125 citations), Pharmaceutical Science (45 citations), Toxicology (17 citations) and Cancer Research (70 citations). Arvind Thakkar has collaborated with scholars based in United States, India and Netherlands. Frequent co-authors include Sunil Prabhu, Jeffrey Wang, Dhruvitkumar S. Sutaria, Zhijun Wang, Muralidhara Padigaru, Girish V. Shah, Baoyue Ding, Ravishankar Ravishankar, Arun Balakrishnan and David K. Ann. Their work appears in journals such as Cancer Research, Cell & Bioscience, International Journal of Oncology, Oncology Reports and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.